Envestnet Asset Management Inc. Boosts Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Envestnet Asset Management Inc. raised its position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 9.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,698 shares of the company's stock after acquiring an additional 3,659 shares during the period. Envestnet Asset Management Inc. owned approximately 0.24% of Addus HomeCare worth $5,352,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of ADUS. Smartleaf Asset Management LLC raised its stake in Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after purchasing an additional 214 shares in the last quarter. Parkside Financial Bank & Trust raised its holdings in shares of Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after buying an additional 148 shares during the period. Meeder Asset Management Inc. purchased a new position in Addus HomeCare during the 4th quarter valued at $77,000. Harvest Fund Management Co. Ltd bought a new position in Addus HomeCare in the 4th quarter valued at $86,000. Finally, KBC Group NV lifted its stake in Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after acquiring an additional 268 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

ADUS has been the subject of several research reports. Stephens reaffirmed an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday, March 12th. JMP Securities reissued a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday. StockNews.com downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Oppenheimer boosted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Finally, Macquarie restated an "outperform" rating and issued a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. One research analyst has rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, Addus HomeCare currently has an average rating of "Buy" and a consensus price target of $139.00.

Addus HomeCare Trading Up 1.0 %

Shares of NASDAQ:ADUS traded up $1.04 on Friday, hitting $100.58. 97,408 shares of the company were exchanged, compared to its average volume of 162,977. The stock's 50 day moving average price is $97.93 and its 200 day moving average price is $116.15. Addus HomeCare Co. has a 1-year low of $88.96 and a 1-year high of $136.72. The firm has a market capitalization of $1.83 billion, a P/E ratio of 23.02, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. On average, equities analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.